BACKGROUND: Alzheimer's disease (AD) is the most common dementing illness. Development of effective treatments directed at AD requires an early diagnosis. Mild cognitive impairment (MCI) often heralds AD. Thus, characterizing MCI is fundamental to the early diagnosis of AD. METHODS: 19 MCI patients referred from a memory loss clinic and 27 healthy subjects, all followed up for 3 years. Metabolism scans (MCI minus controls) were compared voxel-wise after anatomic normalization and were examined both visually and with a computerized classifier. RESULTS: Agreement between raters as to whether the individual scans were normal or abnormal was high. Agreement between raters of the eventual clinical diagnosis and baseline metabolic pattern was poor. A computerized classifier was unsuccessful at classifying MCI from normal; however, its performance improved when using only prototypic AD-like MCI scans, indicating the classifier worked well when shared patterns existed in the data. Outcomes on follow-up were nine of 19 AD, five of 19 remained MCI, and five of 19 developed dementias other than AD. Both MCI cases of early Lewy body dementia (LBD) showed an AD-like metabolic pattern. CONCLUSIONS: Visual inspection proved reliable in determining normal from abnormal scans, but it proved unreliable at predicting diagnosis on follow-up. Computerized classification of MCI by using an AD-like metabolic template (such as derived from the averaged MCI images) showed potential to identify patients who will develop AD. However, the metabolic pattern in early LBD did not differ from that in AD. Published by Elsevier Inc.
BACKGROUND:Alzheimer's disease (AD) is the most common dementing illness. Development of effective treatments directed at AD requires an early diagnosis. Mild cognitive impairment (MCI) often heralds AD. Thus, characterizing MCI is fundamental to the early diagnosis of AD. METHODS: 19 MCIpatients referred from a memory loss clinic and 27 healthy subjects, all followed up for 3 years. Metabolism scans (MCI minus controls) were compared voxel-wise after anatomic normalization and were examined both visually and with a computerized classifier. RESULTS: Agreement between raters as to whether the individual scans were normal or abnormal was high. Agreement between raters of the eventual clinical diagnosis and baseline metabolic pattern was poor. A computerized classifier was unsuccessful at classifying MCI from normal; however, its performance improved when using only prototypic AD-like MCI scans, indicating the classifier worked well when shared patterns existed in the data. Outcomes on follow-up were nine of 19 AD, five of 19 remained MCI, and five of 19 developed dementias other than AD. Both MCI cases of early Lewy body dementia (LBD) showed an AD-like metabolic pattern. CONCLUSIONS: Visual inspection proved reliable in determining normal from abnormal scans, but it proved unreliable at predicting diagnosis on follow-up. Computerized classification of MCI by using an AD-like metabolic template (such as derived from the averaged MCI images) showed potential to identify patients who will develop AD. However, the metabolic pattern in early LBD did not differ from that in AD. Published by Elsevier Inc.
Authors: Alexander Drzezga; Timo Grimmer; Matthias Riemenschneider; Nicola Lautenschlager; Hartwig Siebner; Panagiotis Alexopoulus; Satoshi Minoshima; Markus Schwaiger; Alexander Kurz Journal: J Nucl Med Date: 2005-10 Impact factor: 10.057
Authors: A L Hunderfund; R O Roberts; T C Slusser; C L Leibson; Y E Geda; R J Ivnik; E G Tangalos; R C Petersen Journal: Neurology Date: 2006-11-28 Impact factor: 9.910
Authors: William R Markesbery; Frederick A Schmitt; Richard J Kryscio; Daron G Davis; Charles D Smith; David R Wekstein Journal: Arch Neurol Date: 2006-01
Authors: Lisa Mosconi; Wai Hon Tsui; Alberto Pupi; Susan De Santi; Alexander Drzezga; Satoshi Minoshima; Mony J de Leon Journal: J Nucl Med Date: 2007-06-15 Impact factor: 10.057
Authors: Lisa Mosconi; Wai H Tsui; Karl Herholz; Alberto Pupi; Alexander Drzezga; Giovanni Lucignani; Eric M Reiman; Vjera Holthoff; Elke Kalbe; Sandro Sorbi; Janine Diehl-Schmid; Robert Perneczky; Francesca Clerici; Richard Caselli; Bettina Beuthien-Baumann; Alexander Kurz; Satoshi Minoshima; Mony J de Leon Journal: J Nucl Med Date: 2008-02-20 Impact factor: 10.057
Authors: C R Jack; S D Weigand; M M Shiung; S A Przybelski; P C O'Brien; J L Gunter; D S Knopman; B F Boeve; G E Smith; R C Petersen Journal: Neurology Date: 2007-11-21 Impact factor: 9.910
Authors: Silvia Morbelli; Valentina Garibotto; Elsmarieke Van De Giessen; Javier Arbizu; Gaël Chételat; Alexander Drezgza; Swen Hesse; Adriaan A Lammertsma; Ian Law; Sabina Pappata'; Pierre Payoux; Marco Pagani Journal: Eur J Nucl Med Mol Imaging Date: 2015-09 Impact factor: 9.236
Authors: José V Pardo; Sohail A Sheikh; Graeme Schwindt; Joel T Lee; David E Adson; Barry Rittberg; Faruk S Abuzzahab Journal: PLoS One Date: 2020-01-13 Impact factor: 3.240